celastrol has been researched along with Acute Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Cheng, G; Du, B; Duan, S; Jiao, Q; Pang, M; Yu, L; Zhao, M | 1 |
| Fan, Y; Gong, F; Jiang, X; Pan, M; Sun, Y; Wang, D; Wang, Y; Wang, Z | 1 |
| Ding, G; Huang, S; Jia, Z; Meng, X; Xu, M; Yu, X; Zhang, A; Zhang, X; Zhang, Y | 1 |
3 other study(ies) available for celastrol and Acute Kidney Failure
| Article | Year |
|---|---|
Co-delivery of celastrol and lutein with pH sensitive nano micelles for treating acute kidney injury.
Topics: Acute Kidney Injury; Chitosan; Humans; Hydrogen-Ion Concentration; Lutein; Micelles; Pentacyclic Triterpenes | 2022 |
Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2/GPX4 pathway.
Topics: Acute Kidney Injury; Animals; Cisplatin; Ferroptosis; Inflammation; Iron; Mice; NF-E2-Related Factor 2 | 2023 |
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Biopsy; Cell Line; Cisplatin; Disease Models, Animal; Kidney; Male; Mice; Mitochondria; NF-kappa B; Oxygen Consumption; Pentacyclic Triterpenes; Protective Agents; Reactive Oxygen Species; Signal Transduction; Triterpenes | 2018 |